Literature DB >> 25469279

Predictive value of 18F-fluorodeoxyglucose positron emission tomography - computed tomography compared to postoperative pathological findings for patients with non-small-cell lung cancer.

Jie Xue1, Jinsong Zheng2, Hongbo Guo3, Xiaohui Wang2, Anqin Han4.   

Abstract

This study was conducted to investigate the predictive value of 18F-fluorodeoxyglucose positron emission tomography-computed tomography (18F-FDG PET-CT) in patients with non-small-cell lung cancer (NSCLC), compared to that of postoperative pathological findings, for T and N staging and the associations of the metabolic parameters of the primary tumor with histological type and differentiation. The preoperative contrast-enhanced CT and 18F-FDG PET-CT and postoperative pathological findings of 112 NSCLC patients treated with lobectomy or pneumonectomy combined with systematic mediastinal lymphadenectomy were retrospectively reviewed. Compared to the postoperative pathological findings, the effect of contrast-enhanced CT and 18F-FDG PET-CT on T and N staging were evaluated. The metabolic tumor volume (MTV) and maximum standardized uptake value (SUVmax) of the primary tumor were measured. The associations between these metabolic parameters and histological type and differentiation were also evaluated. The differences in the accuracy in overall staging and T staging between PET-CT and contrast-enhanced CT were significant (91.1 vs. 69.6%, P=0.000; and 92.9 vs. 76.8%, P=0.000, respectively). The sensitivity, specificity, positive predictive value, negative predictive value and accuracy of regional lymph node metastasis detection were 91.7, 93.0, 86.5, 95.8 and 92.6%, respectively, with PET-CT; and 71.3, 77.2, 60.6, 84.5 and 75.2%, respectively, with contrast-enhanced CT. The SUVmax (7.29±1.83 vs. 5.91±1.65, t=4.15, P=0.000) and MTV (48.20±22.47 vs. 30.21±19.72 cm3, t=4.48, P=0.000) were significantly higher for squamous cell carcinoma (SCC) compared to those for adenocarcinoma (AC). There was a positive correlation between the MTV and SUVmax of the primary tumor (Pearson's r=0.838, P=0.000). Significant differences were observed among differentiation subgroups in the SUVmax and MTV of the primary tumor for both SCC and AC. In conclusion, compared to the postoperative pathological findings, the predictive value of 18F-FDG PET-CT for T and N staging in NSCLC was higher compared to that of contrast-enhanced CT. The FDG uptake of the primary tumor was associated with histological type and differentiation and the difference was statistically significant. Therefore, the SUVmax and MTV of the primary tumor may be valuable indices to partly predict the histological type and grade of differentiation of NSCLC.

Entities:  

Keywords:  computed tomography; metabolic tumor volume; non-small-cell lung cancer; positron emission tomography; staging; standardized uptake value

Year:  2014        PMID: 25469279      PMCID: PMC4251154          DOI: 10.3892/mco.2014.408

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  24 in total

1.  FDG PET measurement of the proliferative potential of non-small cell lung cancer.

Authors:  K Higashi; Y Ueda; M Yagishita; Y Arisaka; A Sakurai; M Oguchi; H Seki; Y Nambu; H Tonami; I Yamamoto
Journal:  J Nucl Med       Date:  2000-01       Impact factor: 10.057

2.  The role of surgery in N2 lung cancer.

Authors:  N Martini; B J Flehinger
Journal:  Surg Clin North Am       Date:  1987-10       Impact factor: 2.741

Review 3.  Staging of non-small cell lung cancer (NSCLC): a review.

Authors:  S Tsim; C A O'Dowd; R Milroy; S Davidson
Journal:  Respir Med       Date:  2010-09-15       Impact factor: 3.415

4.  Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma.

Authors:  Weng-Yoon Shum; Te-Chun Hsieh; Jun-Jun Yeh; Jin-Hua Chen; Chih-Chung Su; Ji-An Liang; Chia-Hung Kao
Journal:  Eur J Radiol       Date:  2011-04-01       Impact factor: 3.528

5.  Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET.

Authors:  Gerald Antoch; Nina Saoudi; Hilmar Kuehl; Gerlinde Dahmen; Stefan P Mueller; Thomas Beyer; Andreas Bockisch; Jörg F Debatin; Lutz S Freudenberg
Journal:  J Clin Oncol       Date:  2004-11-01       Impact factor: 44.544

6.  Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study.

Authors:  Ronald Boellaard; Nanda C Krak; Otto S Hoekstra; Adriaan A Lammertsma
Journal:  J Nucl Med       Date:  2004-09       Impact factor: 10.057

7.  A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer.

Authors:  Trevor Leong; Craig Everitt; Kally Yuen; Sara Condron; Andrew Hui; Samuel Y K Ngan; Alexander Pitman; Eddie W F Lau; Michael MacManus; David Binns; Trevor Ackerly; Rodney J Hicks
Journal:  Radiother Oncol       Date:  2006-03-20       Impact factor: 6.280

8.  Microvessel density: correlation with 18F-FDG uptake and prognostic impact in lung adenocarcinomas.

Authors:  JianFei Guo; Kotaro Higashi; Yoshimichi Ueda; Manabu Oguchi; Tsutomu Takegami; Hirohisa Toga; Tsutomu Sakuma; Hajime Yokota; Shogo Katsuda; Hisao Tonami; Itaru Yamamoto
Journal:  J Nucl Med       Date:  2006-03       Impact factor: 10.057

9.  Dual-time-point FDG PET for the evaluation of locoregional lymph nodes in thoracic esophageal squamous cell cancer.

Authors:  Qinyong Hu; Weixing Wang; Xiaojun Zhong; Shuanghu Yuan; Zheng Fu; Hongbo Guo; Jinming Yu
Journal:  Eur J Radiol       Date:  2008-07-03       Impact factor: 3.528

10.  Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer.

Authors:  Minghuan Li; Ningbo Liu; Man Hu; Fang Shi; Shuanghu Yuan; Pinliang Zhang; Zheng Fu; Guoren Yang; Jinming Yu
Journal:  Lung Cancer       Date:  2008-07-16       Impact factor: 5.705

View more
  3 in total

1.  The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status.

Authors:  Ji Soo Park; Nare Lee; Seung Hoon Beom; Hyo Song Kim; Choong-Kun Lee; Sun Young Rha; Hyun Cheol Chung; Mijin Yun; Arthur Cho; Minkyu Jung
Journal:  Gastric Cancer       Date:  2017-06-22       Impact factor: 7.370

2.  Volumetric parameters on 18F-FDG PET/CT predict the survival of patients with gastric cancer associated with their expression status of c-MET.

Authors:  Guobing Liu; Yan Hu; Xi Cheng; Yan Wang; Yushen Gu; Tianshu Liu; Hongcheng Shi
Journal:  BMC Cancer       Date:  2019-08-08       Impact factor: 4.430

3.  N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [18F]FDG PET/CT compared to the histopathology reference standard.

Authors:  Hubertus Hautzel; Yazan Alnajdawi; Wolfgang P Fendler; Christoph Rischpler; Kaid Darwiche; Wilfried E Eberhardt; Lale Umutlu; Dirk Theegarten; Martin Stuschke; Martin Schuler; Clemens Aigner; Ken Herrmann; Till Plönes
Journal:  EJNMMI Res       Date:  2021-07-22       Impact factor: 3.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.